The role of genetic polymorphisms of angiotensin-converting enzyme in the progression of renal diseases

Hypertension

Volumn 28, Issue 5, 1996, Pages 912-915

  McLaughlin, Kevin J ^a   Harden, Paul N ^b   Ueda, Shinichiro ^b   Boulton Jones, J Michael ^a   Connell, John M C ^b   Jardine, Alan G ^b  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

angiotensin converting enzyme; polymorphism; renal disease

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; CHILD; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; GLOMERULOPATHY; HOMOZYGOSITY; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0029907529     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.5.912     Document Type: Conference Paper

References (26)

1. Jeunemaitre X, Soubrier F, Kotelevstev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel J-M, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
2. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, Clark AJL. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 1994;330:1629-1633.
3. Cambien F, Poirer O, Lecerf L, Evans A, Cambou J-P, Arveiler D, Luc G, Bard J-M, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
4. Reynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, Taft CS, Perryman MD. Angiotensin-convening enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet. 1993;342:1073-1075.
5. Marian AJ, Yu Q, Workman R, Greve G, Roberts R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet. 1994;342:1085-1086.
6. Wolf G, Neilson EG. Angiotensin II as a renal growth factor. J Am Soc Nephrol. 1993;3:1531-1540.
7. Doria A, Warram JH, Krolewski AS. Genetic predisposition to diabetic nephropathy: evidence for a role of the angiotensin I converting enzyme gene. Diabetes. 1994;43:690-695.
8. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene T-T, Hallab M, Cambien F, Passa P, Alhenc-Gelas F. Relationship between angiotensin I converting gene polymorphisms, plasma levels, and diabetic retinal and renal complications. Diabetes. 1994;43:690-695.
9. Harden PN, Geddes C, Rowe PA, McIlroy JH, Boulton-Jones M, Rodger RSC, Junor BJR, Briggs JD, Connell JMC, Jardine AG. Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet. 1995;345:1540-1542.
10. Jan Danser AH, Schalekamp MADH, Bax WA, Maassen van der Brink A, Saxena PR, Riegger GAJ, Schunkert H. Angiotensin converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation. 1995;92:1387-1388.
11. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence from combined segregation and linkage analysis, that a variant of the angiotensin-converting enzyme gene controls plasma ACE levels. Am J Hum Genet. 1992;51:197-205.
12. Ueda S, Elliot HE, Morton JJ, Connell JMC. Enhanced pressor response to angiotensin II in normotensive males with deletion genotype (DD) for angiotensin converting enzyme. Hypertension. 1995; 25:1266-1269.
13. Rowe PA, Richardson RE, Burton PR, Morgan AG, Burden RP. Analysis of reciprocal creatinine plots by two-phase linear regression. Am J Nephrol. 1989;9:38-43.
14. Ueda S, Heeley RP, Lees KR, Elliott HL, Connell JMC. Mistyping of the human angiotensin converting enzyme gene polymorphism: frequency, causes and possible methods to avoid typing error. J Mol Endocrinol. In press.
15. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992;20:1433.
16. Shanmugam V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Methods Appl. 1993;3:120-121.
17. Jardine AG. Angiotensin II in glomerulonephritis. J Hypertens. 1995; 13:487-492.
18. Lewis EJ, Hunsicker LG, Bain RP, Rhode RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329:1456-1462.
19. Maschio G, Alberti D, Janin G, Locatelli F, Mann JFE, Motolese M, Ponticello C, Ritz E, Zucchelli P, and the Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insuffiency Study Group. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal failure. N Engl J Med. 1996;334:939-945.
20. Yoshida H, Kawamura T, Mitarai T, Kanai T, Ogura M, Kawamoto S, Kitajima T, Omura K, Abe A, Hamaguchi A, Ischikawa I, Sakai O. Role for the deletion polymorphism in the angiotensin converting enzyme gene in IgA nephropathy. J Am Soc Nephrol. 1994;5(suppl 3):846P.
21. Schmidt S, Schone N, Ritz E, and the diabetic nephropathy study group. Association of the ACE gene and diabetic nephropathy? Kidney Int. 1995;47:1176-1181.
22. Schmidt S, Steir E, Hartung R, Kinterstein G, Banisch J, Woodroffe A, Clarkston AR, Ponticelli C, Campise M, Mayer G, Ganten D, Ritz E. No association of converting enzyme insertion/deletion polymorphism in immunoglobulin A glomerulonephritis. Am J Kidney Dis. 1995;26:727-731.
23. Rosman JB. Protein-restricted diets in chronic renal failure: a four year's follow-up shows limited indications. Kidney Int. 1989;36 (suppl 27):S96-102.
24. Morishita R, Gibbons GH, Ellison KE, Lee W, Zhuang L, Yu H, Kaneda Y, Ogihara T, Dzau VJ. Evidence for direct local effect of angiotensin in vascular hypertrophy: in vivo gene transfer fo angiotensin converting enzyme. J Clin Invest. 1994;94:978-984.
25. Lindpainter K, Pfeffer MA, Kreutz R. Prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischaemic heart disease. N Engl J Med. 1995;322:706-7111.
26. Harden PN, O'Kane KPJ, Ueda S, Connell JMC, Jardine AG. Association studies, ACE polymorphisms and renal disease. Nephrol Dial and Transplant. 1996;757-759.